Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons dr. M.A. Heuvelmans

Publicaties

A comparative analysis of heterogeneity in lung cancer screening effectiveness in two randomised controlled trials

Action plan for an international imaging framework for implementation of global low-dose CT screening for lung cancer

Corrigendum to: Feasibility of AI as first reader in the 4-IN-THE-LUNG-RUN lung cancer screening trial: Impact on negative-misclassifications and clinical referral rate (European Journal of Cancer (2025) 216, 115214 (S0959804924018215), (10.1016/j.ejca.2024.115214))

Cost-effectiveness and budget impact of lung cancer screening in time of immunotherapy

CT-assessed sarcopenia and immune-related adverse events in patients with lung cancer: A competing risk time-to-event analysis

Erratum to ‘Model-Based Cost-Utility Analysis of Combined Low-Dose Computed Tomography Screening for Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease’ [JTO Clinical and Research Reports Volume 6 Issue 5 (2025) 100813] (JTO Clinical and Research Reports (2025) 6(5), (S2666364325000293), (10.1016/j.jtocrr.2025.100813))

Gender Disparities and Lung Cancer Screening Outcomes Among Individuals Who Have Never Smoked

Histological proven AI performance in the UKLS CT lung cancer screening study: potential for workload reduction

Lung cancer screening implementation: turning evidence into practice

Model-Based Cost-Utility Analysis of Combined Low-Dose Computed Tomography Screening for Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease